2-hexyl-4-pentynoic acid, a potential therapeutic for breast carcinoma by influencing RPA2 hyperphosphorylation-mediated DNA repair

Wenwen Ding, David Lim, Zhendong Wang, Zuchao Cai, Guochao Liu, Fengmei Zhang, Zhihui Feng

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Breast carcinoma is one of the most common malignancies in women. Previous studies have reported that 500 μM valproic acid can sensitize breast tumor cells to the anti-neoplastic agent hydroxyurea. However, the dose requirements for valproic acid is highly variable due to the wide inter-individuals clinical characteristics. High therapeutic dose of valproic acid required to induce anti-tumor activity in solid tumor was associated with increased adverse effects. There are attempts to locate suitably high-efficient low-toxicity valproic acid derivatives. We demonstrated that lower dose of 2-hexyl-4-pentynoic acid (HPTA; 15 μM) has similar effects as 500 μM VPA in inhibiting breast cancer cell growth and sensitizing the tumor cells to hydroxyurea on MCF7 cells, EUFA423 cells, MCF7 cells with defective RPA2-p gene and primary culture cells derived from tissue-transformed breast tumor cells. We discovered HPTA resulted in more DNA double-strand breaks, the homologous recombination was inhibited through the interference of the hyperphosphorylation of replication protein A2 and recombinase Rad51. Our data postulate that HPTA may be a potential novel sensitizer to hydroxyurea in the treatment of breast carcinoma.

Original languageEnglish
Article number102940
Number of pages11
JournalDNA Repair
Volume95
DOIs
Publication statusPublished - Nov 2020

Keywords

  • Breast cancer
  • HDACi, histone deacetylase inhibitor
  • HPTA, 2-hexyl-4-pentynoic acid
  • HU, hydroxyurea
  • VPA, valproic acid

Fingerprint Dive into the research topics of '2-hexyl-4-pentynoic acid, a potential therapeutic for breast carcinoma by influencing RPA2 hyperphosphorylation-mediated DNA repair'. Together they form a unique fingerprint.

Cite this